Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-06-26
1977-05-31
Drezin, Norman A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424249, 424269, A61K 31155
Patent
active
040270394
ABSTRACT:
It has been found that compounds having a stereochemically unencumbered access to a nitrogen-nitrogen bond have antiviral activity in extremely low dose ranges. Hydrazine, hydrazine derivatives and related compounds have been found to be active in protecting animals against disease caused by both DNA and RNA type viruses at doses of about 250 picograms to 250 micrograms per kilogram of host body weight.
REFERENCES:
patent: 3429966 (1969-02-01), Gall et al.
patent: 3436461 (1969-04-01), Scotti et al.
patent: 3576844 (1971-04-01), Ishida et al.
patent: 3855242 (1974-12-01), Chapman et al.
Chemical Abstracts 62:15264 c, (1965).
Chemical Abstracts 56:4047 b, (1961).
Chemical Abstracts 62:8139 d, (1965).
Chemical Abstracts 57:17191 f, (1962).
Hegarty Charles Paul
Pietryk Helen C.
American Home Products Corporation
Drezin Norman A.
Weigman Joseph Martin
LandOfFree
Method of viral chemoprophylaxis and compounds therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of viral chemoprophylaxis and compounds therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of viral chemoprophylaxis and compounds therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-658835